Nanna’s unique screening platform has great potential to create novel programs, leading to maximization of mitochondria-related research Image credit- shutterstock.com Japan based Astellas Pharma Inc. and UK based Nanna Therapeutics Limited have announced that Astellas has acquired Nanna, that is focused on addressing age-related diseases with high unmet medical […]
Click here to view original web page at www.biospectrumasia.com